AUSTEDO

This brand name is authorized in Israel, United States

Active ingredients

The drug AUSTEDO contains one active pharmaceutical ingredient (API):

1 Deutetrabenazine
UNII P341G6W9NB - DEUTETRABENAZINE

Deutetrabenazine exerts its effects in the treatment of tardive dyskinesia and chorea in patients with Huntington’s disease. The precise mechanism is unknown but is believed to be related to its effect as a reversible depletor of monoamines (such as dopamine, serotonin, norepinephrine, and histamine) from nerve terminals.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
AUSTEDO Coated tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8758, 8759, 8760
Country: US FDA, National Drug Code Identifier(s): 68546-170, 68546-171, 68546-172

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.